26/01/2021 3:00 PM
Vaccine development: proteins, protections and pandemics
We are delighted to be running an insightful discussion on vaccine development against the backdrop of a pandemic, and an update on the introduction and risks of human challenge trials.
The webinar is aimed at insurance claims handlers, underwriters, start-ups, medical device, med-tech and pharmaceutical companies and in-house counsel, academics and disrupters in the industry.
Professor Ian Kimber, Emeritus Professor of Toxicology in the Faculty of Biology, Medicine and Health, University of Manchester
Professor Kimber will describe the basic features of the human immune system and the ways in which it is deployed to provide host resistance to viral infection.
Professor Michael Scott Kinch, Associate Vice Chancellor, Professor of Biochemistry and Molecular Biophysics, and Director of the Centers for Research Innovation in Biotechnology and Drug Discovery, Washington University
Professor Kinch will cover the history and development of vaccines including the risks to manufacturers, clinicians and patients posed by these developments in the context of a pandemic.
Caroline Speight, Senior Associate, Kennedys
Caroline Speight is also a qualified adult, paediatric and community health nurse.
She will discuss the product liability implications of vaccines and vaccine development, and address the legal and ethical implications of human challenge trials.
If you would like to register your interest in this webinar please contact our events team.